跳至主要内容
临床试验/JPRN-jRCT2080225269
JPRN-jRCT2080225269已完成2 期

ate Phase II Study of TS-142 in Patients with Insomnia

Taisho Pharmaceutical Co., Ltd.0 个研究点目标入组 160 人开始时间: 2020年7月9日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • To be eligible for study participation, an individual must meet all of the following criteria:
  • -Japanese male and female age 20 years or older at the time of informed consent
  • - Outpatients
  • - Patients who meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria for insomnia disorder
  • - Other protocol defined inclusion criteria could apply

排除标准

  • An individual who meets any of the following criteria will be excluded from participation
  • in this study:
  • - Patients who meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria excepting insomnia disorder preceding visit 1
  • - Patients who meet the DSM-5 criteria for Restless legs syndrome at visit 1
  • - Patients with comorbid psychiatric disorder(s), including depression, schizophrenia, anxiety
  • - Other protocol defined exclusion criteria could apply

研究者

相似试验